[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update]

Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):435-54. doi: 10.1016/j.eimc.2011.01.010. Epub 2011 Apr 6.
[Article in Spanish]

Abstract

The guidelines on the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) are presented. These recommendations are focused on four clinical categories: oncology-haematology patients, solid organ transplant recipients, patients admitted to intensive care units, and children. An extensive review is made of therapeutical advances and scientific evidence in these settings. These guidelines have been prepared according the SEIMC consensus rules by a working group composed of specialists in infectious diseases, clinical microbiology, critical care medicine, paediatrics and oncology-haematology. Specific recommendations on the prevention of fungal infections in these patients are included.

Publication types

  • English Abstract
  • Practice Guideline

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy*
  • Aspergillosis / prevention & control
  • Humans
  • Mycoses / drug therapy*
  • Mycoses / prevention & control
  • Organ Transplantation
  • Postoperative Complications / drug therapy
  • Postoperative Complications / prevention & control
  • Risk Factors

Substances

  • Antifungal Agents